| The immunoproteasome: an emerging target in cancer and autoimmune and neurological disorders BL Zerfas, ME Maresh, DJ Trader Journal of Medicinal Chemistry 63 (5), 1841-1858, 2019 | 44 | 2019 |
| Cereblon covalent modulation through structure-based design of histidine targeting chemical probes JT Cruite, GP Dann, J Che, KA Donovan, S Ferrao, SB Ficarro, ES Fischer, ... RSC Chemical Biology 3 (9), 1105-1110, 2022 | 38 | 2022 |
| Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides RJ Cassell, KL Mores, BL Zerfas, AH Mahmoud, MA Lill, DJ Trader, ... European Neuropsychopharmacology 29 (3), 450-456, 2019 | 36 | 2019 |
| Fluorescent probes with unnatural amino acids to monitor proteasome activity in real-time BL Zerfas, RA Coleman, AF Salazar-Chaparro, NJ Macatangay, ... ACS chemical biology 15 (9), 2588-2596, 2020 | 35 | 2020 |
| Monitoring the immunoproteasome in live cells using an activity-based peptide–peptoid hybrid probe BL Zerfas, DJ Trader Journal of the American Chemical Society 141 (13), 5252-5260, 2019 | 30 | 2019 |
| Gramicidin A Mutants with Antibiotic Activity against Both Gram‐Positive and Gram‐Negative Bacteria BL Zerfas, Y Joo, J Gao ChemMedChem 11 (6), 629-636, 2016 | 20 | 2016 |
| Development of a covalent cereblon-based PROTAC employing a fluorosulfate warhead RP Nowak, L Ragosta, F Huerta, H Liu, SB Ficarro, JT Cruite, RJ Metivier, ... RSC Chemical Biology 4 (11), 906-912, 2023 | 16 | 2023 |
| Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives RP Nowak, J Che, S Ferrao, NR Kong, H Liu, BL Zerfas, LH Jones RSC Medicinal Chemistry 14 (3), 501-506, 2023 | 16 | 2023 |
| HiBiT-SpyTag: A Minimal Tag for Covalent Protein Capture and Degrader Development T Tsang, F Huerta, Y Liu, J Che, RJ Metivier, S Ferrao, KA Donovan, ... ACS Chemical Biology 18 (4), 933-941, 2023 | 8 | 2023 |
| Recent advances in peptide immunomodulators B L. Zerfas, J Gao Current Topics in Medicinal Chemistry 16 (2), 187-205, 2016 | 7 | 2016 |
| Advancing targeted protein degrader discovery by measuring cereblon engagement in cells BL Zerfas, F Huerta, H Liu, G Du, NS Gray, LH Jones, RP Nowak Methods in Enzymology 681, 169-188, 2023 | 6 | 2023 |
| Synthesis and Application of an Activity‐Based Peptide‐Peptoid Hybrid Probe for the Immunoproteasome BL Zerfas, DJ Trader Current protocols in chemical biology 11 (4), e76, 2019 | 5 | 2019 |
| Oleic amide derivatives as small molecule stimulators of the human proteasome's core particle S Halder, NJ Macatangay, BL Zerfas, AF Salazar-Chaparro, DJ Trader RSC Medicinal Chemistry 13 (9), 1077-1081, 2022 | 4 | 2022 |
| Rapid capillary mixing experiments for the analysis of hydrophobic membrane complexes directly from aqueous lipid bilayer solutions JW Patrick, B Zerfas, J Gao, DH Russell Analyst 142 (2), 310-315, 2017 | 4 | 2017 |
| Creating Novel Antimicrobial Peptides: From Gramicidin A to Screening a Cyclic Peptide Library BL Zerfas Boston College, 2017 | 2 | 2017 |
| ReSPONDINg TACtically, degrading strategically BL Zerfas, LH Jones Trends in Pharmacological Sciences, 2023 | 1 | 2023 |
| Identification of a covalent binder to the oncoprotein gankyrin using a NIR-Based OBOC screening method ME Maresh, BL Zerfas, BS Wuthrich, DJ Trader RSC advances 11 (21), 12794-12801, 2021 | 1 | 2021 |
| Activity-based probes with unnatural amino acids to monitor proteasome activity DJ Trader, B Zerfas, A Salazar-Chaparro US Patent App. 17/905,921, 2023 | | 2023 |
| Method and composition matter for immunoproteasome-mediated delivery into living cells DJ Trader, B Zerfas US Patent App. 17/428,676, 2022 | | 2022 |
| Protein Degradation Profile Reveals Dynamic Nature of 20S CP Small Molecule Stimulation RA Coleman, TJP Sobreira, U Aryal, D Trader | | 2020 |
